Genetic determinants of telomere length and risk of common cancers: A Mendelian randomization study

Human Molecular Genetics

Volumn 24, Issue 18, 2015, Pages 5356-5366

  Zhang, Chenan ^a   Doherty, Jennifer A ^b   Burgess, Stephen ^c   Hung, Rayjean J ^d   Lindström, Sara ^e   Kraft, Peter ^e   Gong, Jian ^f   Amos, Christopher I ^b   Sellers, Thomas A ^g   Monteiro, Alvaro N A ^g   Chenevix Trench, Georgia ^h   Bickeböller, Heike ⁱ   Risch, Angela ^j,k   Brennan, Paul ^l   Mckay, James D ^l   Houlston, Richard S ^m   Landi, Maria Teresa ⁿ   Timofeeva, Maria N ^l   Wang, Yufei ^m   Heinrich, Joachim ^o   Kote Jarai, Zsofia ^m   Eeles, Rosalind A ^m,p   Muir, Ken ^q,r   Wiklund, Fredrik ^s   Grönberg, Henrik ^s   Berndt, Sonja I ⁿ   Chanock, Stephen J ⁿ   Schumacher, Fredrick ^t   Haiman, Christopher A ^t   Henderson, Brian E ^t   Al Olama, Ali Amin ^c   Andrulis, Irene L ^u   Hopper, John L ^v   Chang Claude, Jenny ^j   John, Esther M ^w,z   Malone, Kathleen E ^f   Gammon, Marilie D ^x   Ursin, Giske ^y   Whittemore, Alice S ^z   Hunter, David J ^e   Gruber, Stephen B ^aa   Knight, Julia A ^u,ab   Hou, Lifang ^ac   Marchand, Loic Le ^ad   Newcomb, Polly A ^f,ae   Hudson, Thomas J ^af   Chan, Andrew T ^ag,ah   Li, Li ^ai   Woods, Michael O ^aj   Ahsan, Habibul ^a   Pierce, Brandon L ^a   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MOUNT SINAI HOSPITAL   (Canada)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ UNIVERSITY OF GÖTTINGEN   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k MEMBER OF THE GERMAN CENTER FOR LUNG RESEARCH DZL   (Germany)

^l INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

^o INSTITUTE OF EPIDEMIOLOGY   (Germany)

^p INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^q UNIVERSITY OF WARWICK   (United Kingdom)

^r UNIVERSITY OF MANCHESTER   (United Kingdom)

^s KAROLINSKA INSTITUTE   (Sweden)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u UNIVERSITY OF TORONTO   (Canada)

^v UNIVERSITY OF MELBOURNE   (Australia)

^w CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^x The University of North Carolina at Chapel Hill   (United States)

^y CANCER REGISTRY OF NORWAY   (Norway)

^z STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ab MOUNT SINAI HOSPITAL   (Canada)

^ac NORTHWESTERN UNIVERSITY   (United States)

^ad UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ae UNIVERSITY OF WASHINGTON   (United States)

^af ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^ag MASSACHUSETTS GENERAL HOSPITAL   (United States)

^ah BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ai CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENDELIAN RANDOMIZATION ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE HOMEOSTASIS; AGED; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RISK;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TELOMERE HOMEOSTASIS;

EID: 84940656427     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv252     Document Type: Article

References (69)

1. D' Adda di Fagagna, F. (2008) Living on a break: cellular senescence as aDNA-damage response. Nat. Rev. Cancer, 8, 512-522.
2. Shawi, M. and Autexier, C. (2008) Telomerase, senescence and ageing. Mech. Ageing Dev., 129, 3-10.
3. Stewart, S.A. and Weinberg, R.A. (2006) Telomeres: cancer to human aging. Annu. Rev. Cell Dev. Biol., 22, 531-557.
4. O'Sullivan, R.J. and Karlseder, J. (2010) Telomeres: protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol., 11, 171-181.
5. Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F. and Kiechl, S. (2010) Telomere length and risk of incident cancer and cancer mortality. J. Am. Med. Assoc., 304, 69-75.
6. Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K.A., Dunning, A.M., Svenson, U., Roos, G., Hosgood, H.D. III, Shen, M. et al. (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One, 6, e20466.
7. Jang, J.S., Choi, Y.Y., Lee, W.K., Choi, J.E., Cha, S.I., Kim, Y.J., Kim, C.H., Kam, S., Jung, T.H. and Park, J.Y. (2008) Telomere length and the risk of lung cancer. Cancer Sci., 99, 1385-1389.
8. Wentzensen, I.M., Mirabello, L., Pfeiffer, R.M. and Savage, S.A. (2011) The association of telomere length and cancer: a metaanalysis. Cancer Epidemiol. Biomarkers Prev., 20, 1238-1250.
9. Qin, Q., Sun, J., Yin, J., Liu, L., Chen, J., Zhang, Y., Li, T., Shi, Y., Wei, S. and Nie, S. (2014) Telomere length in peripheral blood leukocytes is sssociated with risk of colorectal cancer in Chinese population. PLoS One, 9, e88135.
10. Shen, J., Gammon, M.D., Terry, M.B., Wang, Q., Bradshaw, P., Teitelbaum, S.L., Neugut, A.I. and Santella, R.M. (2009) Telomere length, oxidative damage, antioxidants and breast cancer risk. Int. J. Cancer, 124, 1637-1643.
11. Qu, S., Wen, W., Shu, X.-O., Chow, W.-H., Xiang, Y.-B., Wu, J., Ji, B.-T., Rothman, N., Yang, G., Cai, Q. et al. (2013) Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am. J. Epidemiol., 177, 617-624.
12. Weischer, M., Nordestgaard, B.G., Cawthon, R.M., Freiberg, J.J., Tybjærg-Hansen, A. and Bojesen, S.E. (2013) Short telomere length, cancer survival, and cancer risk in 47102 individuals. J. Natl. Cancer Inst., 105, 459-468.
13. Lan, Q., Cawthon, R., Gao, Y., Hu, W., Hosgood, H.D. III, Barone-Adesi, F., Ji, B.-T., Bassig, B., Chow, W.-H., Shu, X. et al. (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung Cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a Prospective Cohort Study among women in China. PLoS One, 8, e59230.
14. Pooley, K.A., Sandhu, M.S., Tyrer, J., Shah, M., Driver, K.E., Luben, R.N., Bingham, S.A., Ponder, B.A.J., Pharoah, P.D.P., Khaw, K.-T. et al. (2010) Telomere length in prospective and retrospective cancer case-control studies. Cancer Res., 70, 3170-3176.
15. Zee, R.Y.L., Castonguay, A.J., Barton, N.S. and Buring, J.E. (2009) Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol. Biomarkers Prev., 18, 2280-2282.
16. Cui, Y., Cai, Q., Qu, S., Chow, W.-H., Wen, W., Xiang, Y.-B., Wu, J., Rothman, N., Yang, G., Shu, X.-O. et al. (2012) Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study. Cancer Epidemiol. Biomarkers Prev., 21, 1807-1813.
17. Lee, J.-J., Nam, C.-E., Cho, S.-H., Park, K.-S., Chung, I.-J. and Kim, H.-J. (2003) Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann. Hematol., 82, 492-495.
18. Schroder, C.P., Wisman, G.B.A., de Jong, S., van der Graaf, W.T. A., Ruiters, M.H.J., Mulder, N.H., de Leij, L.F.M.H., van der Zee, A.G.J. and de Vries, E.G.E. (2001) Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br. J. Cancer, 84, 1348-1353.
19. Codd, V., Nelson, C.P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J.L., Hottenga, J.J., Fischer, K., Esko, T., Surakka, I. et al. (2013) Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet., 45, 422-427.
20. Mangino, M., Hwang, S.-J., Spector, T.D., Hunt, S.C., Kimura, M., Fitzpatrick, A.L., Christiansen, L., Petersen, I., Elbers, C. C., Harris, T. et al. (2012) Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum. Mol. Genet., 21, 5385-5394.
21. Pooley, K.A., Bojesen, S.E., Weischer, M., Nielsen, S.F., Thompson, D., Amin Al Olama, A., Michailidou, K., Tyrer, J.P., Benlloch, S., Brown, J. et al. (2013) A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum. Mol. Genet., 22, 5056-5064.
22. Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371-384.
23. Peters, U., Hutter, C., Hsu, L., Schumacher, F., Conti, D., Carlson, C., Edlund, C., Haile, R., Gallinger, S., Zanke, B. et al. (2012) Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet., 131, 217-234.
24. Rafnar, T., Sulem, P., Stacey, S.N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K.K.H. et al. (2009) Sequence variants at the TERTCLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
25. Didelez, V. and Sheehan, N. (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat. Methods Med. Res., 16, 309-330.
26. Kaminski, B.M., Amos, C.I., DeRycke, E., Gillanders, E.M., Gruber, S.B., Henderson, B.E., Hunter, D.J., Lepage, P.K., Sellers, T. A. and Seminara, D. (2012) Genetic Associations and Mechanisms in Oncology (GAME-ON): A network approach to post-GWAS research. Cancer Epidemiol. Biomarkers Prev., 21, 78-78.
27. Dastani, Z., Hivert, M.-F., Timpson, N., Perry, J.R.B., Yuan, X., Scott, R.A., Henneman, P., Heid, I.M., Kizer, J.R., Lyytikäinen, L.-P. et al. (2012) Novel loci for adiponectin levels and their influence on Type 2 diabetes andmetabolic traits: a multi-ethnicmeta-analysis of 45, 891 individuals. PLoS Genet., 8, e1002607.
28. Burgess, S., Butterworth, A. and Thompson, S.G. (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol., 37, 658-665.
29. Johnson, T. (2012) Efficient Calculation for Multi-SNP Genetic Risk Scores. Poster presentation, American Society of Human Genetics Annual Meeting, San Francisco, CA.
30. Burgess, S., Scott, R., Timpson, N., Davey Smith, G. and Thompson, S. (2015) Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol., doi.10.1007/s10654-015-0011-z.
31. Wu, X., Amos, C.I., Zhu, Y., Zhao, H., Grossman, B.H., Shay, J. W., Luo, S., Hong, W.K. and Spitz, M.R. (2003) Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst., 95, 1211-1218.
32. Hosgood, H.D. III, Cawthon, R., He, X., Chanock, S. and Lan, Q. (2009) Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer, 66, 157-161.
33. Sanchez-Espiridion, B., Chen, M., Chang, J.Y., Lu, C., Chang, D. W., Roth, J.A., Wu, X. and Gu, J. (2014) Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res., 74, 2476-2486.
34. Shen, M., Cawthon, R., Rothman, N., Weinstein, S.J., Virtamo, J., Hosgood, H.D. III, Hu, W., Lim, U., Albanes, D. and Lan, Q. (2011) A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer, 73, 133-137.
35. Seow, W.J., Cawthon, R.M., Purdue, M.P., Hu, W., Gao, Y.-T., Huang, W.-Y., Weinstein, S.J., Ji, B.-T., Virtamo, J., Hosgood, H.D. et al. (2014) Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res., 74, 4090-4098.
36. Shaffer, J.A., Epel, E., Kang, M.S., Ye, S., Schwartz, J.E., Davidson, K.W., Kirkland, S., Honig, L.S. and Shimbo, D. (2012) Depressive Symptoms are not associated with leukocyte telomere length: findings fromthe Nova Scotia Health Survey (NSHS95), a population-based study. PLoS One, 7, e48318.
37. Puterman, E., Lin, J., Krauss, J., Blackburn, E.H. and Epel, E.S. (2015) Determinants of telomere attrition over 1 year in healthy older women: stress and health behaviors matter. Mol. Psychiatry, 20, 529-535.
38. Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A. and Spector, T. (2005) Obesity, cigarette smoking, and telomere length in women. The Lancet, 366, 662-664.
39. Timofeeva, M.N., Hung, R.J., Rafnar, T., Christiani, D.C., Field, J.K., Bickeböller, H., Risch, A., McKay, J.D., Wang, Y., Dai, J. et al. (2012) Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum. Mol. Genet., 21, 4980-4995.
40. Daraselia, N., Wang, Y., Budoff, A., Lituev, A., Potapova, O., Vansant, G., Monforte, J., Mazo, I. and Ossovskaya, V.S. (2012) Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers. Am. J. Cancer Res., 2, 98-103.
41. Sekido, Y., Fong, K.M. and Minna, J.D. (2003) Molecular genetics of lung cancer. Annu. Rev. Med., 54, 73-87.
42. Petersen, I., Bujard, M., Petersen, S., Wolf, G., Goeze, A., Schwendel, A., Langreck, H., Gellert, K., Reichel, M., Just, K. et al. (1997) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res., 57, 2331-2335.
43. Machiela, M.J., Hsiung, C.A., Shu, X.-O., Seow, W.J., Wang, Z., Matsuo, K., Hong, Y.-C., Seow, A., Wu, C., Hosgood, H.D. et al. (2015) Genetic variants associatedwith longer telomere length are associated with increased lung cancer risk among neversmoking women in Asia: a report from the female lung cancer consortium in Asia. Int. J. Cancer, 137, 311-319.
44. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N.P. and Jackson, S.P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature, 426, 194-198.
45. Bull, C.F., Mayrhofer, G., O'Callaghan, N.J., Au, A.Y., Pickett, H. A., Low, G.K.M., Zeegers, D., Hande, M.P. and Fenech, M.F. (2014) Folate deficiency induces dysfunctional long and short telomeres; both states are associated with hypomethylation and DNA damage in human WIL2-NS cells. Cancer Prev. Res. Phila. Pa, 7, 128-138.
46. Halaschek-Wiener, J., Vulto, I., Fornika, D., Collins, J., Connors, J.M., Le, N.D., Lansdorp, P.M. and Brooks-Wilson, A. (2008) Reduced telomere length variation in healthy oldest old. Mech. Ageing Dev., 129, 638-641.
47. Iles, M.M., Bishop, D.T., Taylor, J.C., Hayward, N.K., Brossard, M., Cust, A.E., Dunning, A.M., Lee, J.E., Moses, E.K., Akslen, L. A. et al. (2014) The effect on melanoma risk of genes previously associated with Telomere Length. J. Natl. Cancer Inst., 106, doi: 10.1093/jnci/dju267.
48. Bataille, V., Kato, B.S., Falchi, M., Gardner, J., Kimura, M., Lens, M., Perks, U., Valdes, A.M., Bennett, D.C., Aviv, A. et al. (2007) Nevus Size and number are associated with telomere length and represent potential Markers of a decreased senescence in vivo. Cancer Epidemiol. Biomarkers Prev., 16, 1499-1502.
49. Aviv, A., Chen, W., Gardner, J.P., Kimura, M., Brimacombe, M., Cao, X., Srinivasan, S.R. and Berenson, G.S. (2009) Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am. J. Epidemiol., 169, 323-329.
50. Lubin, J.H. and Blot, W.J. (1984) Assessment of lung cancer risk factors by histologic category. J. Natl. Cancer Inst., 73, 383-389.
51. Hurwitz, L.M., Heaphy, C.M., Joshu, C.E., Isaacs, W.B., Konishi, Y., De Marzo, A.M., Isaacs, S.D., Wiley, K.E., Platz, E.A. and Meeker, A.K. (2014) Telomere length as a risk factor for hereditary prostate cancer. The Prostate, 74, 359-364.
52. Mirabello, L., Huang, W.-Y., Wong, J.Y.Y., Chatterjee, N., Reding, D., David Crawford, E., De Vivo, I., Hayes, R.B. and Savage, S.A. (2009) The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell, 8, 405-413.
53. Jones, A.M., Beggs, A.D., Carvajal-Carmona, L., Farrington, S., Tenesa, A., Walker, M., Howarth, K., Ballereau, S., Hodgson, S.V., Zauber, A. et al. (2012) TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut, 61, 248-254.
54. Peters, U., Jiao, S., Schumacher, F.R., Hutter, C.M., Aragaki, A.K., Baron, J.A., Berndt, S.I., Bézieau, S., Brenner, H., Butterbach, K. et al. (2013) Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology, 144, 799-807.e24.
55. Martinez-Delgado, B., Yanowsky, K., Inglada-Perez, L., de la Hoya, M., Caldes, T., Vega, A., Blanco, A., Martin, T., Gonzalez-Sarmiento, R., Blasco, M. et al. (2012) Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J. Med. Genet., 49, 341-344.
56. Mirabello, L., Garcia-Closas, M., Cawthon, R., Lissowska, J., Brinton, L., Peplońska, B., Sherman, M. and Savage, S. (2010) Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control, 21, 77-82.
57. Terry, K.L., Tworoger, S.S., Vitonis, A.F., Wong, J., Titus-Ernstoff, L., De Vivo, I. and Cramer, D.W. (2012) Telomere length and genetic variation in telomeremaintenance genes in relation to ovarian cancer risk. Cancer Epidemiol. Biomarkers Prev., 21, 504-512.
58. Kyo, S., Takakura, M., Kanaya, T., Zhuo, W., Fujimoto, K., Nishio, Y., Orimo, A. and Inoue, M. (1999) Estrogen activates telomerase. Cancer Res., 59, 5917-5921.
59. Lin, J., Kroenke, C.H., Epel, E., Kenna, H.A., Wolkowitz, O.M., Blackburn, E. and Rasgon, N.L. (2011) Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Window Oppor. Menopause Estrogens Brain, 1379, 224-231.
60. Martínez, P. and Blasco, M.A. (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer, 11, 161-176.
61. Anderson, B.H., Kasher, P.R., Mayer, J., Szynkiewicz, M., Jenkinson, E.M., Bhaskar, S.S., Urquhart, J.E., Daly, S.B., Dickerson, J.E., O'Sullivan, J. et al. (2012) Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet, 44, 338-342.
62. Pierce, B.L., Ahsan, H. and Vanderweele, T.J. (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol., 40, 740-752.
63. Saferali, A., Lee, J., Sin, D.D., Rouhani, F.N., Brantly, M.L. and Sandford, A.J. (2014) Longer telomere length in COPD patients with α1-antitrypsin deficiency independent of lung function. PLoS One, 9, e95600.
64. Alder, J.K., Chen, J.J.-L., Lancaster, L., Danoff, S., Su, S., Cogan, J.D., Vulto, I., Xie, M., Qi, X., Tuder, R.M. et al. (2008) Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci., 105, 13051-13056.
65. Daniali, L., Benetos, A., Susser, E., Kark, J.D., Labat, C., Kimura, M., Desai, K.K., Granick, M. and Aviv, A. (2013) Telomeres shorten at equivalent rates in somatic tissues of adults. Nat. Commun., 4, 1597.
66. Aviv, A., Hunt, S.C., Lin, J., Cao, X., Kimura, M. and Blackburn, E. (2011) Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res., 39, e134-e134.
67. Johnson, A.D., Handsaker, R.E., Pulit, S.L., Nizzari, M.M., O'Donnell, C.J. and de Bakker, P.I.W. (2008) SNAP: a webbased tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics, 24, 2938-2939.
68. Eeles, R.A., Olama, A.A.A., Benlloch, S., Saunders, E.J., Leongamornlert, D.A., Tymrakiewicz, M., Ghoussaini, M., Luccarini, C., Dennis, J., Jugurnauth-Little, S. et al. (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet., 45, 385-391, 391e1-2.
69. Brion, M.-J.A., Shakhbazov, K. and Visscher, P.M. (2013) Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol., 42, 1497-1501.